The effect of different chemoembolization materials on CT-based attenuation correction in PET/CT;Effekt verschiedener chemoembolisationsmaterialien auf die CT-basierte schwächungskorrektur der PET/CT

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 179, Issue 11, 2007, Pages 1159-1165

  Heusner, Till Alexander ^a   Fronz, U ^a   Jentzen, W ^a   Verhagen, R ^a   Forsting, M ^a   Bockisch, A ^a   Antoch, C ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Chemoembolization; Experimental study; Hepatic arteries; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINATED POPPYSEED OIL; PLATINUM; TANTALUM; TUNGSTEN;

ARTICLE; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

CHEMOEMBOLIZATION, THERAPEUTIC; FLUORODEOXYGLUCOSE F18; HUMANS; IODIZED OIL; LIVER NEOPLASMS; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TANTALUM; TOMOGRAPHY, X-RAY COMPUTED; TUNGSTEN;

EID: 36348964798     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963402     Document Type: Article

References (31)

1. Yamada R, Nakatsuka H, Nakamura K et al. Hepatic artery embolization in 32 patients with unresectable hepatoma. Osaka City Med J 1980; 26: 81-96
2. Yamada R, Sato M, Kawabata M et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148: 397-401
3. Ito K, Taniyama K, Hattori F et al. Preoperative chemoembolization of iopamiron-solved adriamycin and lipiodol on hepatocellular carcinoma-clinicopathological study of ten surgical cases. Gan To Kagaku Ryoho 1988; 15: 2549-2556
4. Kiely JM, Rilling WS, Touzios JG et al. Chemoembolization in patients at high risk: results and complications. J Vasc Interv Radiol 2006; 17: 47-53
5. Chang AE, Schneider PD, Sugarbaker PH et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206: 685-693
6. Kemeny N, Daly J, Reichman B et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 1987; 107: 459-465
7. Hohn DC, Stagg RJ, Friedman MA et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 1989; 7: 1646-1654
8. Pentecost MJ. Transcatheter treatment of hepatic metastases. Am J Roentgenol 1993; 160: 1171-1175
9. Gerhards A, Mildenberger P, Herber S et al. Möglicher Nutzen und Auswirkung einer Lipiodolmarkierung auf die Histologie beim hepatozellulären Karzinom. Fortschr Röntgenstr 2005; 177: 1380-1386
10. Kan Z, Wright K, Wallace S. Ethiodized oil emulsions in hepatic microcirculation: in vivo microscopy in animal models. Acad Radiol 1997; 4: 275-282
11. Strunk H, Bucerius J, Jaeger U et al. PET-CT in der Nachsorge des kolorektalen Karzinoms: Einfluss der Bildfusion auf die Staginggenauigkeit. Fortschr Röntgenstr 2005; 177: 1235-1241
12. Vogl TJ, Pegios W, Bechstein WO et al. Radiologische Diagnostik des Rektumkarzinoms: Nachsorge und Rezidivdiagnostik. Fortschr Röntgenstr 2006; 178: 970-978
13. Kinahan PE, Townsend DW, Beyer T et al. Attenuation correction for a combined 3D PET/CT scanner. Med Phys 1998; 25: 2046-2053
14. Vogel MN, Brechtel K, Klein MD et al. Vergleich verschiedener Atem-und Kontrastmittelprotokolle bezüglich Bild- und Koregistrierungsqualität bei 18F-FDG-PET/CT-Untersuchungen. Fortschr Röntgenstr 2007; 179: 72-79
15. Hubbell JH. Photon mass attenuation and mass energy-absorption coefficients for H, C, N, O, Ar, and seven mixtures from 0.1 keV to 20 MeV. Radiat Res 1977; 70: 58-81
16. Goenes GW, Ziegler SI, Burger C et al. Artifacts at PET and PET/CT cau-sed by metallic hip prosthetic material. Radiology 2003; 226: 577-584
17. Kamel EM, Burger C, Buck A et al. Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner. Eur Radiol 2003; 13: 724-728
18. Antoch G, Freudenberg LS, Egelhof T et al. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med 2002; 43: 1339-1342
19. Antoch G, Jentzen W, Freudenberg LS et al. Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging. Invest Radiol 2003; 38: 784-789
20. Cohade C, Osman M, Nakamoto Y et al. Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med 2003; 44: 412-416
21. Nakamoto Y, Chin BB, Kraitchman DL et al. Effects of nonionic intravenous contrast agents at PET/CT imaging: phantom and canine studies. Radiology 2003; 227: 817-824
22. Karp JS, Daube-Witherspoon ME, Hoffman EJ et al. Performance standards in positron emission tomography. J Nucl Med 1991; 32: 2342-2350
23. Burger C, Goenes G, Schoenes S et al. PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients. Eur J Nucl Med Mol Imaging 2002; 29: 922-927
24. Rosenbaum SJ, Lind T, Antoch G et al. False-positive FDG PET uptake - the role of PET/CT. Eur Radiol 2006; 16: 1054-1065
25. Antoch G, Vogt FM, Veit P et al. Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. J Nucl Med 2005; 46: 520-525
26. Kinahan PE, Alessio AM, Fessler JA. Dual energy CT attenuation correction methods for quantitative assessment of response to cancer therapy with PET/CT imaging. Technol Cancer Res Treat 2006; 5: 319-327
27. Nehmeh SA, Erdi YE, Kalaigian H et al. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT. J Nucl Med 2003; 44: 1940-1944
28. Nakamoto Y, Osman M, Cohade C et al. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images. J Nucl Med 2002; 43: 1137-1143
29. Varela M, Real MI, Burrel M et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 2007; 46: 474-481
30. Aliberti C, Tilli M, Benea G et al. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. Anticancer Res 2006; 26: 3793-3795
31. Lewis AL, Gonzalez MV, Lloyd AW et al. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 2006; 17: 335-342